Emerging threats of H5N1 clade 2.3.4.4b: cross-species transmission, pathogenesis, and pandemic risk
Riaz-M Azeem, Riaz-M Azeem, Ying-Shi Yang and 13 more
Frontiers in Cellular and Infection Microbiology · 2025
doi:10.3389/fcimb.2025.1625665 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
H5N1 is a highly pathogenic avian influenza virus (HPAIV) with zoonotic potential, posing a significant risk to animal health, agriculture, and human public health. A particular strain, clade 2.3.4.4b, has spread globally and has been detected in various mammalian species—including cattle and a limited number of human cases—highlighting its potential to spark a pandemic. Investigating this specific clade represents a crucial step toward the development of effective preventive and therapeutic strategies. This mini-review aims to outline the etiology and pathophysiological mechanisms driving the current bird flu outbreak in cattle. A targeted literature search was conducted in PubMed for studies published between 2003 and 2025 using keywords such as “bird flu”, “cattle”, “mammals”, “H5N1”, and “pathogenesis”. This review explores the pathogenic mechanisms and clinical manifestations associated with HPAIV H5N1 infections in mammals specially in cattle. A key hypothesis is that the ongoing outbreak is fueled by molecular adaptations in the virus that enhance its ability to cross species barriers. As these mechanisms continue to be uncovered, there is a pressing need for high-quality research to inform pandemic preparedness, guide effective control strategies, and support the development of targeted vaccines and antiviral therapies.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.